Jianlu Dai

Title: Jianlu Dai: Innovator in Biosynthetic Gene Clusters

Introduction

Jianlu Dai is a prominent inventor based in Liaoning, China. He has made significant contributions to the field of biotechnology, particularly in the area of biosynthetic gene clusters. His work has implications for the development of new pharmaceuticals and biotechnological applications.

Latest Patents

Jianlu Dai holds a patent for a biosynthetic gene cluster of carrimycin. This innovative patent comprises 44 gene open reading frames (orf), which include various components essential for polyketide synthesis and modification. The gene cluster features 5 orfs encoding polyketide synthase, 9 orfs related to polyketone synthesis extension units, and 16 orfs associated with glycosyl synthesis. Additionally, it includes orfs related to glycosyl transfer, resistance, and regulation, along with a resistance marker gene and a transferase gene. This patent represents a significant advancement in the understanding and application of biosynthetic pathways.

Career Highlights

Jianlu Dai is affiliated with Shenyang Fuyang Pharmaceutical Technology Co., Ltd., where he continues to push the boundaries of research and innovation. His work has garnered attention in the scientific community, contributing to advancements in pharmaceutical technology.

Collaborations

Jianlu Dai collaborates with notable colleagues, including Yiguang Wang and Yang Jiang. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Jianlu Dai's contributions to the field of biotechnology, particularly through his patent on the biosynthetic gene cluster of carrimycin, highlight his role as an innovator. His work not only advances scientific knowledge but also paves the way for future developments in pharmaceuticals.